Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 4
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT06297863Phase 2Recruiting

Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke

Role: collaborator

NCT05903040Completed

Ditan Acute tReatments: Effectiveness and Tolerability (DART)

Role: collaborator

NCT06414044Active Not Recruiting

Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

Role: collaborator

NCT06409832Recruiting

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

Role: collaborator

NCT05903027Recruiting

Gepant treAtments: EffectIveNess and tolERability (GAINER)

Role: collaborator

NCT07255547Phase 4Active Not Recruiting

PRP vs AD-SVF in Addition to Marrow Stimulation for Knee Chondral Lesion

Role: lead

NCT04400981Not ApplicableCompleted

Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies

Role: collaborator

NCT06409845Recruiting

Effectiveness and Tolerability of Eptinezumab

Role: collaborator

NCT05851755Enrolling By Invitation

Italian Lung Cancer Observational Study

Role: collaborator

NCT04863963Completed

Milligan-Morgan Versus Dearterialization With Mucopexy

Role: lead

NCT01690806Completed

Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy

Role: lead

All 11 trials loaded